Some of the drug treatments available include:
Immunotherapy medications slow the frequency and severity of attacks, which means the myelin sheaths are subjected to less damage; works by modifying the activity of the immune system; most often prescribed for people with relapsing-remitting MS
Methylprednisolone is taken as pills or an infusion; steroid medication is used to control the severity of an MS attack, by easing inflammation at the affected site
Immune suppressants such as methotrexate or mitozantrone, are sometimes used, especially for people with progressive MS
Treatments in development, a large number of new therapies being trialled in the treatment of MS
Get advice about medications
MS Australia does not recommend a particular therapy as this is a clinical decision which you need to make with your neurologist.
MS staff can provide detailed information about medications and discuss what's important in your personal decision making process: contact your state MS society.
Medications Fact Sheets
Current information regarding the status of these treatments is provided below:
A new MS medication - Ocrelizumab (Ocrevus™) has now been approved by the TGA for use in Australia to treat both relapsing and primary progressive forms of MS, making it the first ever TGA approved medication for primary progressive MS (PPMS).
Roche Pharmaceuticals have made two submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) for Pharmaceutical Benefits Scheme (PBS) listing, to make the drug affordable:
A Product Familiarisation Program will be opened in the coming months, allowing RRMS patients to access Ocrelizumab.
Ocrevus will be available for PPMS patients to purchase privately, in the coming months.
For more information visit:
MS Research Australia:
A Treatment Sheet is currently in development.
|Movectro® (cladribine)||Movectro® (cladribine) is an oral medication used to treat relapsing remitting MS. It has been shown to result in fewer relapses, less disease activity in the brain and less progression of disability.||
Movectro® tablets are currently registered in Australia (by the TGA) and the supplier, Merck Serono, is working with health authorities to make it available to patients.
If you'd like to be more informed about what specific treatments are available, download the corresponding fact sheets and discuss these treatments with your doctor or neurologist.
Comparing different MS medications
Treatment for specific symptoms
- Muscle problems: a combination of medication may ease muscle problems, including stiffness and tremors. Physiotherapy is also recommended.
- Fatigue: some studies have found that medication used to treat the sleep disorder narcolepsy is helpful in controlling MS-related fatigue.
- Neurological symptoms: visual disturbances can be helped with medication, including steroids.
- Continence treatment for continence problems may include special exercises, medications, continence aids (such as disposable pads) and certain dietary changes.
- Neuropsychological problems: treatment for depression or anxiety may include counselling or medication; memory problems and other cognitive difficulties can be better managed with professional help from a neuropsychologist.
Seek professional advice
Get advice from your neurologist or GP about what medical treatments and self-management strategies might be most suitable for you.
Support for you
Every person's experience of living with MS is different. Find the support and services you need to meet your individual circumstances.
Visit MS Research Australia for the latest news and information on multiple sclerosis research.